ANP (Human, 1-28)

<strong>ANP (Human, 1-28)</strong>_x000D_ <strong>Catalog number:</strong> MDP0506_x000D_ <strong>CAS Number: </strong>133605-57-9_x000D_ <strong>Sequence: </strong>Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr (Disulfide bond between Cys7-Cys23)_x000D_ <strong>Amount:</strong> 500 ug_x000D_ <strong>Molecular Weight:</strong> 3080.4 g/mol_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>WARNING:</strong> For in vitro Research Use Only. NOT for use on humans or animals._x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Gunnarsson U. Intracerebroventricular ANP(1-28) has no obvious effects on renal blood flow and function in conscious sheep Clin Exp Pharmacol Physiol. 1994 Mar;21(3):189-94._x000D_ 2: Gianello P, Carlier M, Jamart J, Hulhoven R, Bernheim J, Bernard A, Ketelslegers JM, Squifflet JP. Effect of 1-28 alpha-h atrial natriuretic peptide on acute renal failure in cadaveric renal transplantation Clin Transplant. 1995 Dec;9(6):481-9._x000D_ 3: Ronit A, Kirkegaard-Klitbo DM, Dohlmann TL, Lundgren J, Sabin CA, Phillips AN, Nordestgaard BG, Afzal S. Plasma Albumin and Incident Cardiovascular Disease: Results From the CGPS and an Updated Meta-Analysis Arterioscler Thromb Vasc Biol. 2020 Feb;40(2):473-482._x000D_ 4: Macheret F, Heublein D, Costello-Boerrigter LC, Boerrigter G, McKie P, Bellavia D, Mangiafico S, Ikeda Y, Bailey K, Scott CG, Sandberg S, Chen HH, Malatino L, Redfield MM, Rodeheffer R, Burnett J Jr, Cataliotti A. Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP J Am Coll Cardiol. 2012 Oct 16;60(16):1558-65._x000D_ 5: Hamad AM, Johnson SR, Knox AJ. Antiproliferative effects of NO and ANP in cultured human airway smooth muscle Am J Physiol. 1999 Nov;277(5):L910-8._x000D_ 6: Kohno M, Yasunari K, Yokokawa K, Murakawa K, Horio T, Takeda T. Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells J Clin Invest. 1991 Jun;87(6):1999-2004._x000D_ 7: Brandt I, Lambeir AM, Ketelslegers JM, Vanderheyden M, Scharpé S, De Meester I. Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form Clin Chem. 2006 Jan;52(1):82-7._x000D_ 8: Wambach G, Stimpel M, Bönner G. [Atrial natriuretic peptide and its significance for arterial hypertension] Klin Wochenschr. 1989 Nov 3;67(21):1069-76._x000D_ 9: Hughes A, Thom S, Goldberg P, Martin G, Sever P. Direct effect of alpha-human atrial natriuretic peptide on human vasculature in vivo and in vitro Clin Sci (Lond). 1988 Feb;74(2):207-11._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/1334838">10: Delporte C, Winand J, Poloczek P, Von Geldern T, Christophe J. Discovery of a potent atrial natriuretic peptide antagonist for ANPA receptors in the human neuroblastoma NB-OK-1 cell line Eur J Pharmacol. 1992 Dec 2;224(2-3):183-8. </a>_x000D_ _x000D_ <strong>Products Related to ANP (Human, 1-28) can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>